Published in JAMA on December 04, 1987
An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature (2012) 2.35
Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. J Behav Med (2006) 1.62
Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol (2010) 1.22
Effectiveness of a skin cancer control educational intervention for internal medicine housestaff and attending physicians. J Gen Intern Med (1997) 0.98
Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? Lab Invest (2013) 0.92
Head and neck melanoma. ISRN Surg (2012) 0.89
How does pheomelanin synthesis contribute to melanomagenesis?: Two distinct mechanisms could explain the carcinogenicity of pheomelanin synthesis. Bioessays (2013) 0.88
Treatment and outcomes of melanoma in acral location in Korean patients. Yonsei Med J (2010) 0.88
Preventive strategies and research for ultraviolet-associated cancer. Environ Health Perspect (1995) 0.87
Sun protection practices and sun exposure among children with a parental history of melanoma. Cancer Epidemiol Biomarkers Prev (2015) 0.85
Melanoma Risk and Survival among Organ Transplant Recipients. J Invest Dermatol (2015) 0.85
Effects of a short messaging service-based skin cancer prevention campaign in adolescents. Am J Prev Med (2014) 0.83
Relationship between risk factors, knowledge and preventive behaviour relevant to skin cancer in general practice patients in south Australia. Br J Gen Pract (1995) 0.83
Melanoma risk factors and atypical moles. West J Med (1994) 0.83
Sun-protective behaviors in populations at high risk for skin cancer. Psychol Res Behav Manag (2013) 0.83
On the clinical significance of cutaneous melanoma's precursors. Indian Dermatol Online J (2012) 0.79
Giant congenital melanocytic nevi: a case report. J Clin Diagn Res (2012) 0.79
New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapy. Drug Healthc Patient Saf (2014) 0.77
Melanoma: A new strategy to reduce morbidity and mortality. Australas Med J (2014) 0.76
Brazilian guidelines for diagnosis, treatment and follow-up of primary cutaneous melanoma - Part II. An Bras Dermatol (2016) 0.75
Melanoma: Molecular Pathogenesis and Therapeutic Management. Mol Cell Pharmacol (2015) 0.75
Utility of sun-reactive skin typing and melanin index for discerning vitamin D deficiency. Pediatr Res (2017) 0.75
The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer (1996) 4.46
Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med (1974) 4.38
Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol (1994) 3.49
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol (2000) 2.86
Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man. J Exp Med (1973) 2.75
Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med (1979) 2.71
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67
Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics (1989) 2.61
Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol (1977) 2.53
Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol (1999) 2.50
Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol (1975) 2.36
Melanoma in children. N Engl J Med (1995) 2.35
Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases. Am J Dermatopathol (1996) 2.30
Phototesting and dosimetry for photochemotherapy. Br J Dermatol (1977) 2.17
Evaluation of topical agents that prevent sunburn--superiority of para-aminobenzoic acid and its ester in ethyl alcohol. N Engl J Med (1969) 2.13
Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two distinct histopathological entities. J Cutan Pathol (1987) 1.92
Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol (2001) 1.91
Photochemotherapy for psoriasis with orally administered methoxsalen. Arch Dermatol (1976) 1.89
Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg (1981) 1.86
Dermal dendritic melanocytic proliferations: an update. Histopathology (2004) 1.84
Narrower margins for clinical stage I malignant melanoma. N Engl J Med (1982) 1.82
Primary melanoma of the skin: recognition and management. J Am Acad Dermatol (1980) 1.82
A new immunologic marker for human Langerhans cells. N Engl J Med (1981) 1.79
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol (2001) 1.77
An estimate of the annual direct cost of treating cutaneous melanoma. J Am Acad Dermatol (1998) 1.76
Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol (1981) 1.76
Basophilic leukocytes in allergic contact dermatitis. J Exp Med (1972) 1.75
Melastatin expression and prognosis in cutaneous malignant melanoma. J Clin Oncol (2001) 1.75
Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med (1979) 1.74
Characterization of Langerhans cells by the use of monoclonal antibodies. Lab Invest (1981) 1.73
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72
Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer (1997) 1.71
A generalised scan statistic test for the detection of clusters. Int J Epidemiol (1981) 1.71
Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology. Mod Pathol (1989) 1.71
Pilomatrix carcinoma or calcifying epitheliocarcinoma of Malherbe: a case report and review of literature. Cancer (1980) 1.70
Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab Invest (1976) 1.70
Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest (1974) 1.68
Lentigo maligna and lentigo-maligna melanoma. Am J Pathol (1969) 1.68
Squamoid eccrine ductal carcinoma. Histopathology (1997) 1.67
The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med (1971) 1.65
Does biopsy type influence survival in clinical stage I cutaneous melanoma? J Am Acad Dermatol (1985) 1.64
Mechanism of depigmentation by hydroquinone. J Invest Dermatol (1974) 1.62
Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical, and ultrastructural observations. J Am Acad Dermatol (1991) 1.59
Is the self-counting of moles a valid method of assessing melanoma risk? Arch Dermatol (2000) 1.58
Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol (1991) 1.54
Transmittance spectra and theoretical sun protection factors for a series of sunscreen-containing sun care products. Photodermatol Photoimmunol Photomed (1999) 1.51
Bullous dermatosis of hemodialysis. Ann Intern Med (1975) 1.47
Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Am J Surg Pathol (1996) 1.45
The natural break points for primary-tumor thickness in clinical Stage I melanoma. N Engl J Med (1981) 1.45
Actin-binding protein expression in benign and malignant melanocytic proliferations. Hum Pathol (1994) 1.44
Origin of cutaneous melanoma in a congenital dysplastic nevus spilus. Arch Dermatol (1990) 1.43
Early melanoma. Histologic terms. Am J Dermatopathol (1991) 1.43
Acral lentiginous melanoma (including in situ melanoma) arising in association with naevocellular naevi. Melanoma Res (1996) 1.42
Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J (2000) 1.41
Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser. Br J Dermatol (2014) 1.40
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38
Sun exposure habits in patients with cutaneous melanoma: a case control study. J Dermatol Surg Oncol (1983) 1.37
Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies. Hum Pathol (1973) 1.36
Melanoma of oronasal mucosa. Population-based analysis of occurrence and mortality. Arch Otolaryngol Head Neck Surg (1996) 1.35
Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J Invest Dermatol (1982) 1.35
Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest (1992) 1.34
Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg (1981) 1.34
Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer (1976) 1.33
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery (1981) 1.33
Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer (1995) 1.33
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci U S A (1996) 1.31